Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Transplantation. 2020 Mar;104(3):542–550. doi: 10.1097/TP.0000000000002908

Table 3b.

Risk factors for delayed graft function in HCV positive SLK recipients.

Adjusted incidence-rate ratios 95% confidence interval p-value
Recipient pretransplant dialysis: none Reference -- --
 Any 3.00 0.64, 14.01 0.2
 < 6 weeks dialysis 4.90 0.70, 34.3 0.1
 ≥ 6 weeks dialysis 2.80 0.56, 13.90 0.2
Donor BMI, per 5 kg/m2 0.77 0.50, 1.19 0.2
DCD 0.48 0.06, 3.92 0.5
Donor share type – Local Reference -- --
 Regional 0.50 0.16, 1.54 0.2
 National 1.54 0.43, 5.46 0.5
Recipient age, per year 1.03 0.96, 1.10 0.4
Recipient female 0.66 0.15, 3.00 0.6
MELD 1.03 0.91, 1.16 0.7
Recipient race – white Reference -- --
 Black 1.95 0.66, 5.74 0.2
 Hispanic 1.92 0.69, 5.31 0.2
Recipient status: not hospitalized Reference -- --
 Hospitalized, in ICU 0.27 0.05, 1.37 0.1
 Hospitalized, not in ICU 0.32 0.05, 2.10 0.2
Donor age, per year 1.03 1.00, 1.06 0.1
Donor race – white Reference -- --
 Black 1.93 0.31, 12.13 0.5
 Hispanic 1.10 0.29, 4.20 0.9
Donor creatinine, per mg/dL 0.52 0.17, 1.63 0.3
Donor warm ischemia time, min 1.02 0.97, 1.08 0.4
Donor cold ischemia time, liver, hours 0.94 0.82, 1.07 0.4
Kidney on machine perfusion 0.80 0.27, 2.39 0.7
Transplant year 1.11 0.90, 1.37 0.3
Use of induction immunosuppression 4.58 1.00, 21.40 0.1